613 related articles for article (PubMed ID: 32272395)
1. 4-hydroxybenzo[d]oxazol-2(3H)-one ameliorates LPS/D-GalN-induced acute liver injury by inhibiting TLR4/NF-κB and MAPK signaling pathways in mice.
Wang H; Wei X; Wei X; Sun X; Huang X; Liang Y; Xu W; Zhu X; Lin X; Lin J
Int Immunopharmacol; 2020 Jun; 83():106445. PubMed ID: 32272395
[TBL] [Abstract][Full Text] [Related]
2. Protective effects of sea buckthorn polysaccharide extracts against LPS/d-GalN-induced acute liver failure in mice via suppressing TLR4-NF-κB signaling.
Liu H; Zhang W; Dong S; Song L; Zhao S; Wu C; Wang X; Liu F; Xie J; Wang J; Wang Y
J Ethnopharmacol; 2015 Dec; 176():69-78. PubMed ID: 26494508
[TBL] [Abstract][Full Text] [Related]
3. Pretreatment with
Wang X; Han C; Qin J; Wei Y; Qian X; Bao Y; Shi W
J Interferon Cytokine Res; 2019 Aug; 39(8):495-505. PubMed ID: 31074668
[TBL] [Abstract][Full Text] [Related]
4. Oxyresveratrol prevents lipopolysaccharide/d-galactosamine-induced acute liver injury in mice.
Jia YN; Lu HP; Peng YL; Zhang BS; Gong XB; Su J; Zhou Y; Pan MH; Xu L
Int Immunopharmacol; 2018 Mar; 56():105-112. PubMed ID: 29414639
[TBL] [Abstract][Full Text] [Related]
5. Hepatoprotective effect of quercetin against LPS/d-GalN induced acute liver injury in mice by inhibiting the IKK/NF-κB and MAPK signal pathways.
Peng Z; Gong X; Yang Y; Huang L; Zhang Q; Zhang P; Wan R; Zhang B
Int Immunopharmacol; 2017 Nov; 52():281-289. PubMed ID: 28963941
[TBL] [Abstract][Full Text] [Related]
6. Quercetin disrupts tyrosine-phosphorylated phosphatidylinositol 3-kinase and myeloid differentiation factor-88 association, and inhibits MAPK/AP-1 and IKK/NF-κB-induced inflammatory mediators production in RAW 264.7 cells.
Endale M; Park SC; Kim S; Kim SH; Yang Y; Cho JY; Rhee MH
Immunobiology; 2013 Dec; 218(12):1452-67. PubMed ID: 23735482
[TBL] [Abstract][Full Text] [Related]
7. Propofol attenuates inflammatory response and apoptosis to protect d-galactosamine/lipopolysaccharide induced acute liver injury via regulating TLR4/NF-κB/NLRP3 pathway.
Zhang Z; Tian L; Jiang K
Int Immunopharmacol; 2019 Dec; 77():105974. PubMed ID: 31735662
[TBL] [Abstract][Full Text] [Related]
8. Dioscin reduces lipopolysaccharide-induced inflammatory liver injury via regulating TLR4/MyD88 signal pathway.
Yao H; Hu C; Yin L; Tao X; Xu L; Qi Y; Han X; Xu Y; Zhao Y; Wang C; Peng J
Int Immunopharmacol; 2016 Jul; 36():132-141. PubMed ID: 27135544
[TBL] [Abstract][Full Text] [Related]
9. Protective effects of morin on lipopolysaccharide/d-galactosamine-induced acute liver injury by inhibiting TLR4/NF-κB and activating Nrf2/HO-1 signaling pathways.
Tian Y; Li Z; Shen B; Zhang Q; Feng H
Int Immunopharmacol; 2017 Apr; 45():148-155. PubMed ID: 28213269
[TBL] [Abstract][Full Text] [Related]
10. Hepatocyte-Conditional Knockout of Phosphatidylethanolamine Binding Protein 4 Aggravated LPS/D-GalN-Induced Acute Liver Injury
Qu XQ; Chen QF; Shi QQ; Luo QQ; Zheng SY; Li YH; Bai LY; Gan S; Zhou XY
Front Immunol; 2022; 13():901566. PubMed ID: 35874667
[TBL] [Abstract][Full Text] [Related]
11. Propofol Inhibits Lipopolysaccharide-Induced Inflammatory Responses in Spinal Astrocytes via the Toll-Like Receptor 4/MyD88-Dependent Nuclear Factor-κB, Extracellular Signal-Regulated Protein Kinases1/2, and p38 Mitogen-Activated Protein Kinase Pathways.
Zhou CH; Zhu YZ; Zhao PP; Xu CM; Zhang MX; Huang H; Li J; Liu L; Wu YQ
Anesth Analg; 2015 Jun; 120(6):1361-8. PubMed ID: 25695672
[TBL] [Abstract][Full Text] [Related]
12. Helenalin from Centipeda minima ameliorates acute hepatic injury by protecting mitochondria function, activating Nrf2 pathway and inhibiting NF-κB activation.
Li Y; Zeng Y; Huang Q; Wen S; Wei Y; Chen Y; Zhang X; Bai F; Lu Z; Wei J; Lin X
Biomed Pharmacother; 2019 Nov; 119():109435. PubMed ID: 31520915
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein A5 alleviates LPS/D-GalN-induced fulminant liver failure in mice by inhibiting TLR4-mediated NF-κB pathway.
Tao YC; Wang ML; Wu DB; Luo C; Tang H; Chen EQ
J Transl Med; 2019 May; 17(1):151. PubMed ID: 31077206
[TBL] [Abstract][Full Text] [Related]
14. Hepatoprotective effect of cryptotanshinone from Salvia miltiorrhiza in D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure.
Jin Q; Jiang S; Wu YL; Bai T; Yang Y; Jin X; Lian LH; Nan JX
Phytomedicine; 2014 Jan; 21(2):141-7. PubMed ID: 24011530
[TBL] [Abstract][Full Text] [Related]
15. Reduced hepatic injury in Toll-like receptor 4-deficient mice following D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure.
Ben Ari Z; Avlas O; Pappo O; Zilbermints V; Cheporko Y; Bachmetov L; Zemel R; Shainberg A; Sharon E; Grief F; Hochhauser E
Cell Physiol Biochem; 2012; 29(1-2):41-50. PubMed ID: 22415073
[TBL] [Abstract][Full Text] [Related]
16. Pretreatment of lipopolysaccharide (LPS) ameliorates D-GalN/LPS induced acute liver failure through TLR4 signaling pathway.
Zhang S; Yang N; Ni S; Li W; Xu L; Dong P; Lu M
Int J Clin Exp Pathol; 2014; 7(10):6626-34. PubMed ID: 25400741
[TBL] [Abstract][Full Text] [Related]
17. β-Caryophyllene alleviates D-galactosamine and lipopolysaccharide-induced hepatic injury through suppression of the TLR4 and RAGE signaling pathways.
Cho HI; Hong JM; Choi JW; Choi HS; Hwan Kwak J; Lee DU; Kook Lee S; Lee SM
Eur J Pharmacol; 2015 Oct; 764():613-621. PubMed ID: 26254779
[TBL] [Abstract][Full Text] [Related]
18. Protective effects of ginsenoside Rg1 against lipopolysaccharide/d-galactosamine-induced acute liver injury in mice through inhibiting toll-like receptor 4 signaling pathway.
Ning C; Gao X; Wang C; Huo X; Liu Z; Sun H; Yang X; Sun P; Ma X; Meng Q; Liu K
Int Immunopharmacol; 2018 Aug; 61():266-276. PubMed ID: 29902710
[TBL] [Abstract][Full Text] [Related]
19. Protective effect of chloral hydrate against lipopolysaccharide/D-galactosamine-induced acute lethal liver injury and zymosan-induced peritonitis in mice.
Pan Q; Liu Y; Zheng J; Lu X; Wu S; Zhu P; Fu N
Int Immunopharmacol; 2010 Aug; 10(8):967-77. PubMed ID: 20669364
[TBL] [Abstract][Full Text] [Related]
20. CQMUH-011, a novel adamantane sulfonamide compound, inhibits lipopolysaccharide- and D-galactosamine-induced fulminant hepatic failure in mice.
Yan L; Hu X; Wu Q; Jiang R; Zhang S; Ling Q; Liu H; Jiang X; Wan J; Liu Y
Int Immunopharmacol; 2017 Jun; 47():231-243. PubMed ID: 28433945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
